Risk that the continuation or performance of the pharmaceutical and long-term care businesses may be affected by the revocation or non-renewal of licenses and approvals under the Pharmaceuticals and Medical Devices Act, the Long-Term Care Insurance Act and other laws, as well as by amendments to laws and regulations and the need to comply with regulatory requirements.